American Century Companies’s Fulcrum Therapeutics FULC Stock Holding History

American Century Companies's FULC Position: Q2 2026 in Review

American Century Companies reduced its Fulcrum Therapeutics (FULC) stake by 0.24% in Q2 2026, selling an estimated $2.27K and leaving 155,868 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #2554.

American Century Companies first reported a position in FULC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.78M in Q4 2025. 141 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

• American Century Companies held 155,868 shares of Fulcrum Therapeutics worth $570K as of Q2 2026.
• American Century Companies sold 374 Fulcrum Therapeutics shares in Q2 2026, an estimated $2.27K.
• Fulcrum Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2554 holding.
• American Century Companies first reported a position in Fulcrum Therapeutics in Q1 2023 and has held it in 14 quarters since.
• American Century Companies's Fulcrum Therapeutics position peaked at $1.78M in Q4 2025.
• 141 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.